Insulet (NASDAQ:PODD) Stock Rating Upgraded by Wolfe Research

Insulet (NASDAQ:PODD – Get Free Report) was upgraded by Wolfe Research from a “peer perform” rating to an “outperform” rating in a report issued on Tuesday, Briefing.com reports. The firm currently has a $200.00 price target on the medical instruments supplier’s stock. Wolfe Research’s target price suggests a potential upside of 13.38% from the company’s […]

Leave a Reply

Your email address will not be published.

Previous post SThree plc (LON:STEM) Declares Dividend Increase – GBX 11.60 Per Share
Next post Advanced Energy Industries (NASDAQ:AEIS) Price Target Increased to $113.00 by Analysts at Citigroup